Harvard Bioscience (HBIO) Competitors $0.41 +0.00 (+1.02%) Closing price 10/24/2025 04:00 PM EasternExtended Trading$0.42 +0.01 (+2.72%) As of 10/24/2025 07:49 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock HBIO vs. TMO, A, MTD, WAT, ILMN, TECH, CRL, BIO, BRKR, and PACBShould you be buying Harvard Bioscience stock or one of its competitors? The main competitors of Harvard Bioscience include Thermo Fisher Scientific (TMO), Agilent Technologies (A), Mettler-Toledo International (MTD), Waters (WAT), Illumina (ILMN), Bio-Techne (TECH), Charles River Laboratories International (CRL), Bio-Rad Laboratories (BIO), Bruker (BRKR), and Pacific Biosciences of California (PACB). These companies are all part of the "life sciences tools & services" industry. Harvard Bioscience vs. Its Competitors Thermo Fisher Scientific Agilent Technologies Mettler-Toledo International Waters Illumina Bio-Techne Charles River Laboratories International Bio-Rad Laboratories Bruker Pacific Biosciences of California Harvard Bioscience (NASDAQ:HBIO) and Thermo Fisher Scientific (NYSE:TMO) are both life sciences tools & services companies, but which is the superior business? We will compare the two businesses based on the strength of their risk, profitability, dividends, institutional ownership, valuation, analyst recommendations, earnings and media sentiment. Do analysts recommend HBIO or TMO? Harvard Bioscience presently has a consensus target price of $2.00, suggesting a potential upside of 390.32%. Thermo Fisher Scientific has a consensus target price of $595.75, suggesting a potential upside of 3.96%. Given Harvard Bioscience's higher possible upside, equities analysts plainly believe Harvard Bioscience is more favorable than Thermo Fisher Scientific.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Harvard Bioscience 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00Thermo Fisher Scientific 0 Sell rating(s) 5 Hold rating(s) 19 Buy rating(s) 0 Strong Buy rating(s) 2.79 Do institutionals & insiders hold more shares of HBIO or TMO? 80.9% of Harvard Bioscience shares are owned by institutional investors. Comparatively, 89.2% of Thermo Fisher Scientific shares are owned by institutional investors. 9.5% of Harvard Bioscience shares are owned by company insiders. Comparatively, 0.3% of Thermo Fisher Scientific shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. Which has better valuation and earnings, HBIO or TMO? Thermo Fisher Scientific has higher revenue and earnings than Harvard Bioscience. Harvard Bioscience is trading at a lower price-to-earnings ratio than Thermo Fisher Scientific, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioHarvard Bioscience$94.14M0.19-$12.40M-$1.30-0.31Thermo Fisher Scientific$42.88B5.05$6.34B$17.3133.11 Is HBIO or TMO more profitable? Thermo Fisher Scientific has a net margin of 15.02% compared to Harvard Bioscience's net margin of -64.68%. Thermo Fisher Scientific's return on equity of 16.97% beat Harvard Bioscience's return on equity.Company Net Margins Return on Equity Return on Assets Harvard Bioscience-64.68% -5.64% -2.15% Thermo Fisher Scientific 15.02%16.97%8.49% Does the media prefer HBIO or TMO? In the previous week, Thermo Fisher Scientific had 97 more articles in the media than Harvard Bioscience. MarketBeat recorded 99 mentions for Thermo Fisher Scientific and 2 mentions for Harvard Bioscience. Harvard Bioscience's average media sentiment score of 1.89 beat Thermo Fisher Scientific's score of 1.10 indicating that Harvard Bioscience is being referred to more favorably in the media. Company Overall Sentiment Harvard Bioscience Very Positive Thermo Fisher Scientific Positive Which has more volatility & risk, HBIO or TMO? Harvard Bioscience has a beta of 1.52, indicating that its share price is 52% more volatile than the S&P 500. Comparatively, Thermo Fisher Scientific has a beta of 0.77, indicating that its share price is 23% less volatile than the S&P 500. SummaryThermo Fisher Scientific beats Harvard Bioscience on 12 of the 16 factors compared between the two stocks. Get Harvard Bioscience News Delivered to You Automatically Sign up to receive the latest news and ratings for HBIO and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding HBIO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HBIO vs. The Competition Export to ExcelMetricHarvard BioscienceINSTRU IndustryComputer SectorNASDAQ ExchangeMarket Cap$18.16M$1.02B$33.67B$10.81BDividend YieldN/A0.51%3.18%4.81%P/E Ratio-0.3128.66105.6630.95Price / Sales0.191.111,290.97133.74Price / Cash4.0417.1238.6161.86Price / Book0.282.217.626.61Net Income-$12.40M$17.67M$820.47M$277.10M7 Day Performance7.54%3.57%2.47%2.57%1 Month Performance-7.13%3.62%3.63%3.79%1 Year Performance-82.42%-14.07%24,146.25%33.01% Harvard Bioscience Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HBIOHarvard Bioscience4.0561 of 5 stars$0.41+1.0%$2.00+390.3%-82.6%$18.16M$94.14M-0.31490Positive NewsAnalyst ForecastTMOThermo Fisher Scientific4.7564 of 5 stars$524.80flat$589.10+12.3%+2.8%$198.17B$42.88B30.35125,000Trending NewsEarnings ReportAnalyst ForecastAnalyst RevisionAAgilent Technologies3.7446 of 5 stars$138.43+1.3%$148.69+7.4%+13.2%$38.73B$6.51B32.4917,900Positive NewsAnalyst ForecastMTDMettler-Toledo International4.091 of 5 stars$1,289.13+1.2%$1,336.50+3.7%+11.0%$26.24B$3.87B32.6417,300News CoveragePositive NewsAnalyst ForecastAnalyst RevisionWATWaters4.1196 of 5 stars$336.83+1.8%$377.56+12.1%+9.6%$19.70B$2.96B30.377,600Trending NewsAnalyst ForecastILMNIllumina4.6928 of 5 stars$95.03+1.2%$123.56+30.0%-29.2%$14.43B$4.37B12.039,030Upcoming EarningsAnalyst ForecastTECHBio-Techne4.3783 of 5 stars$59.65+1.7%$70.17+17.6%-3.6%$9.13B$1.22B129.683,100Positive NewsAnalyst ForecastCRLCharles River Laboratories International4.2919 of 5 stars$170.85+2.3%$179.93+5.3%+8.1%$8.22B$4.05B-128.4620,100Analyst DowngradeBIOBio-Rad Laboratories4.4228 of 5 stars$303.56+2.0%$333.50+9.9%+3.7%$8.06B$2.57B25.887,700News CoverageUpcoming EarningsBRKRBruker4.9093 of 5 stars$36.23+2.7%$51.00+40.8%-33.2%$5.35B$3.37B69.6711,396News CoverageAnalyst ForecastAnalyst RevisionPACBPacific Biosciences of California0.7493 of 5 stars$1.62+14.1%$1.90+17.3%+17.4%$426.53M$154.01M-0.71730Analyst ForecastGap UpHigh Trading Volume Related Companies and Tools Related Companies TMO Competitors A Competitors MTD Competitors WAT Competitors ILMN Competitors TECH Competitors CRL Competitors BIO Competitors BRKR Competitors PACB Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:HBIO) was last updated on 10/25/2025 by MarketBeat.com Staff From Our PartnersIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMove $1,000 into this stock before Nov 6The End of Tesla? "Hold onto your Tesla stock." That's the message insiders at Tesla have been giving staff...Altimetry | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | Sponsored$4,200 gold is nice ... but here’s what most gold bugs are missingGold just surged past $4,200, but Weiss Ratings expert Sean Brodrick says the real upside is in select gold st...Weiss Ratings | SponsoredFront-Run Buffett's Shocking Gold MoveA Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredBuy UBER immediatelyBULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Harvard Bioscience, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Harvard Bioscience With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.